Back to Dashboard
EW · Healthcare

EDWARDS LIFESCIENCES CORP

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
44
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. EDWARDS LIFESCIENCES CORP is not currently in our model portfolio, but 8 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$49.4B
Industry
Medical Devices
Exchange
NYSE
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name;…
8
Investors
1
New positions
3
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
D.E. Shaw & Co
Trust weight: 1.0×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of D.E. Shaw & Co's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +242%
% of portfolio
0.4%
Position change
+242%
0.4% of Millennium Management's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +8%
% of portfolio
0.1%
Position change
+8%
0.1% of AQR Capital Management's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Increased +266%
% of portfolio
0.0%
Position change
+266%
0.0% of Gotham Asset Mgmt's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −48%
% of portfolio
0.1%
Position change
−48%
0.1% of Citadel Advisors's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Decreased −39%
% of portfolio
0.1%
Position change
−39%
0.1% of Point72's portfolio
Baillie Gifford & Co
Trust weight: 1.4×
Decreased −10%
% of portfolio
0.0%
Position change
−10%
0.0% of Baillie Gifford & Co's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −57%
% of portfolio
0.0%
Position change
−57%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to EDWARDS LIFESCIENCES CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell EDWARDS LIFESCIENCES CORP or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API